Xylooligosaccharide Market

How Big is the Xylooligosaccharide Market in 2026?

Sales of xylooligosaccharide will expand at a 6.1% CAGR between 2026 and 2036. Market value is estimated at USD 44.3 Million in 2026, up from USD 41.8 Million in 2025, and will reach USD 79.6 Million by 2036.

Xylooligosaccharide market size is estimated at USD 44.3 Million in 2026, up from USD 41.8 Million in 2025, and FMI projects revenue of USD 79.6 Million by 2036 at a 6.1% CAGR, a gain of USD 35.3 Million. Set against the USD 2,407.9 Million animal feed prebiotics pool, XOS remains a very small line, though a faster growth rate means the category is gaining ground from that small base. A June 2026 review in Food, Nutrition and Health described XOS prebiotics as increasingly recognized non-antibiotic feed additives that improve animal health and productivity [1]. The same review named agro-industrial waste as a major cost-reduction route for livestock use and flagged high-purity, high-yield industrial refining as an unresolved challenge [1]. Share gains against older prebiotics will therefore track refining cost per kilogram as closely as gut-health science, and corncob processors with integrated xylitol lines are holding a cost advantage.

Neighboring gut-health categories will add much larger sums over the same decade, giving XOS producers several outlets beyond straight feed prebiotics. Revenue from animal feed prebiotics will rise from USD 2,407.9 Million in 2026 to USD 3,922.2 Million by 2036 at a 5.0% CAGR, an opportunity of USD 1,514.3 Million. The eubiotic feed additives market is set to expand from USD 5,120.0 Million to USD 10,651.1 Million at a 7.6% CAGR, widening by USD 5,531.1 Million. Sales of pet gut health supplements will gain USD 2,500.3 Million at a 9.6% CAGR, moving from USD 1,666.0 Million to USD 4,166.3 Million, the fastest rate of the three.

A 6.1% CAGR against 5.0% for feed prebiotics rests on dose economics, since low inclusion rates let one ton of XOS treat a very large volume of compound feed. Analysts at FMI expect investment in feed-grade powder capacity and in poultry and swine trial data to separate the suppliers gaining share from those selling on price through 2036.

Key Takeaways of Xylooligosaccharide Market

• Dry xylooligosaccharide will hold 69.7% of form market share in 2026.
• By product type, livestock applications will account for 64.3% of market share in 2026.
• Key companies operating in the xylooligosaccharide market include Shandong Longlive Bio-Technology Co., Ltd., Baolingbao Biology Co., Ltd., Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., DSM-Firmenich, and Roquette Frères, and the full report covers many more players.
• Japan will grow fastest at a 7.8% CAGR, and Russia will grow slowest at 3.7% as feed mills there stay with familiar gut-health tools.

Analyst Perspective

“Xylooligosaccharide will grow fastest as a low-dose gut health additive in livestock and pet nutrition, as feed makers are looking for proven alternatives to antibiotic growth promoters. The biggest opportunity lies in dry, heat-stable grades backed by species-specific trial data, as poultry, swine and premium pet food producers will pay for measurable gains in gut health and feed efficiency.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Xylooligosaccharide Market Segmented?

The market is split by form, product type and region, with dry and liquid grades sold into livestock and pet applications.

Form covers dry and liquid.
Product type covers livestock and pet.

Why Does Dry Lead the Xylooligosaccharide Market by Form?

Dry xylooligosaccharide will account for 69.7% of form market share in 2026, as powder grades fit existing premix lines.

A feed mill adding a new gut-health ingredient wants the same dosing, storage and blending steps already used for vitamins and enzymes, and powder XOS fits those systems without new handling equipment. FMI expects dry grades to keep the largest form position on that basis through the forecast period. Liquid XOS will keep a role in wet dosing systems and syrup-based treats, though water weight raises freight cost per unit of active ingredient.

• Premix and compound-feed compatibility will give dry XOS 69.7% of form revenue in 2026.
• In July 2025, Shandong Bailong Chuangyuan Bio-Tech listed XOS among intestinal health additives for livestock and poultry and reported the ingredient as stable after one hour at 120°C [2].

Why Does Livestock Lead the Xylooligosaccharide Market by Product Type?

Livestock applications will account for 64.3% of product type market share in 2026 on the strength of poultry and swine feed volumes.

Poultry and swine programs give XOS suppliers repeated dosing across very large feed volumes, and research output is deepest in these species. A September 2025 study in Frontiers in Veterinary Science found that 500 mg/kg of XOS lowered the feed-to-gain ratio of weaning pigs by 5.1% and raised ileal villus height by 11.6% [3]. Buyers will convert such gains into cost per kilogram of liveweight before approving a formula change. Uptake will also follow the probiotic feed supplements category, as synbiotic programs pair XOS with live strains.

• High feed volumes and species-specific evidence will hand livestock 64.3% of product type revenue in 2026.
• In July 2025, The Journal of Poultry Science published a study in which 1.6 g/kg of XOS restored average daily gain in Escherichia coli-challenged broilers from 6.59 g to 7.03 g, close to the 7.12 g of unchallenged birds [4].

What are the Drivers, Restraints, and Opportunities in the Xylooligosaccharide Market?

FMI's analysis sees the search for non-antibiotic gut-health tools driving sales till 2036, with approval and trial requirements slowing conversion and pet nutrition opening a smaller, higher-value revenue pool.

• Driver: Feed formulators are adding prebiotic tools that support gut function and feed efficiency without antibiotic growth promoters.
• Restraint: Feed-additive approval rules and species-specific efficacy trials lengthen the path from sample to recurring order.
• Opportunity: Adoption potential of XOS in pet food premix and companion-animal gut-health formats favors low-dose, palatable grades.

Performance data supply the pull, since the June 2026 review in Food, Nutrition and Health reported that XOS in broiler feed significantly increased body-weight gain, improved feed efficiency and reduced abdominal fat percentage [1]. Cost sits on the other side of the ledger, as the same review noted that enzymatic hydrolysis is still expensive and needs biomass pretreatment [1]. Regulation adds a second filter in markets such as Japan, which designates feed additives only when necessity is high, effects are clear and safety is confirmed [5]. Pet nutrition offers a separate outlet, with the review also linking dietary XOS to stronger immunity and higher gut microbiota diversity in kittens [1]. Suppliers pairing low-cost hydrolysis with registered, trial-backed grades will convert more feed and pet trials into contracts during the forecast period.

Which Country CAGRs are Profiled in the Xylooligosaccharide Market?

Country	CAGR, 2026 to 2036
Japan	7.8%
Canada	6.8%
USA	5.7%
UK	5.3%
Germany	5.0%
France	4.4%
Italy	4.1%
Russia	3.7%

How do Country-level CAGRs Compare in the Xylooligosaccharide Market?

Japan and Russia sit 4.1 percentage points apart, at 7.8% and 3.7%, and FMI's country model places the other six profiled markets inside that band through 2036. Canada follows Japan at 6.8%, the USA, the UK and Germany cluster between 5.0% and 5.7%, and France at 4.4% and Italy at 4.1% sit just above Russia. A low growth rate says nothing about base size, so a slower-growing market such as the USA can still carry a larger revenue base than Japan.

• Canada sits 1.0 point behind Japan, with a hog herd large enough to support repeat premix orders.
• French demand at 4.4% will come from productivity gains in a mature pig and poultry sector with little herd expansion ahead.
• Italy grows 3.7 points slower than Japan, and Istat reported in September 2026 that pig numbers fell 15.6% between 2006 and 2025 [6].
• Russian feed mills will keep leaning on established gut-health tools and price-led formulas, holding XOS growth to 3.7%, the slowest profiled rate.

Regional coverage extends past these eight markets to North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, with CAGRs for more than 25 countries and country groups.

Country Outlook

• Japan's 7.8% CAGR, the fastest among profiled countries, will come through a regulatory gate. MAFF designates feed additives only when necessity is high, effects are clear and safety is confirmed, after review by three expert bodies [5]. In December 2025, MAFF approved a J-Credit methodology covering two designated methane-reducing feed additives, 3-nitrooxypropanol (3-NOP) and cashew nut shell liquid [7]. Designation status is turning into a commercial asset in Japanese feed, and XOS suppliers holding complete dossiers and local trial data will reach mills sooner.
• Statistics Canada counted 14.0 million hogs on farms on July 1, 2026, up 0.6% from a year earlier, and cattle and calf inventories rose 3.2% to 12.1 million head, the largest gain since 2004 [8]. Growing swine and cattle herds give premix suppliers repeat volume, and Canadian demand for XOS will rise at a 6.8% CAGR through 2036.
• A shrinking US hog herd is shifting the sales case for XOS toward output per animal. USDA NASS counted 74.3 million hogs and pigs on US farms on September 1, 2026, down 2.0% from a year earlier [9]. Integrators feeding fewer pigs will look for feed-efficiency gains per head, a case that suits trial-backed prebiotics and supports a 5.7% CAGR through 2036.
• In the UK, broiler growth is setting the pace for a 5.3% CAGR till 2036. DEFRA data show total UK poultry rose 4.1% to 183 million birds in 2025, with broilers up 7.6% to 121 million, and pig numbers stayed close to 4.7 million [10]. Long compound-feed runs for broilers suit dry XOS, which enters the same premix stream as other powdered additives.
• Fewer and larger German pig farms are concentrating purchasing power, and XOS demand there will grow at a 5.0% CAGR. Destatis counted 21.0 million pigs on 14,700 farms on May 3, 2026, with farm numbers down 3.6% in a year [11]. Average herd size rose from about 1,100 to 1,400 pigs over ten years [11]. Each formula approval at a large integrated unit will now move a bigger share of national demand.

Who are the Notable Companies in the Xylooligosaccharide Market?

Key companies in the market include Shandong Longlive Bio-Technology Co., Ltd., Baolingbao Biology Co., Ltd., Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., COFCO Biotechnology Co., Ltd., DSM-Firmenich, and Roquette Frères.

Supply of xylooligosaccharide is concentrated in China, and a few corncob-based functional sugar producers hold most of the capacity. Entry barriers will stay high because direct makers such as Shandong Longlive and Shandong Bailong Chuangyuan run XOS as one stream of a wider xylitol and functional sugar operation. Product documentation is becoming the main basis of competition at the feed mill, and Bailong Chuangyuan lists XOS among intestinal health additives for livestock and poultry, stable after one hour at 120°C [2]. Baolingbao and COFCO Biotechnology compete on processing scale and feed reach, and Baolingbao lists a feed subsidiary, Yucheng Baolikang Biological Feed, among group companies [12]. Consolidation is arriving from the animal nutrition side, as DSM-Firmenich agreed in February 2026 to divest Animal Nutrition & Health to CVC Capital Partners [13]. Roquette secured prebiotic verification for NUTRIOSE fibers the same month, bringing third-party proof into the fiber side of the market [14].

Pricing power through 2036 will sit with suppliers holding species-specific feed data, heat-stable dry grades and export registrations, according to FMI, as more feed and pet food buyers ask for trial-backed prebiotics. Producers selling commodity XOS on price alone will face steady margin pressure from the same shift.

• Direct XOS Manufacturers: Shandong Longlive Bio-Technology Co., Ltd. and Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. produce XOS alongside xylitol or other functional sugars for feed and food buyers.
• Functional Sugar Groups with Feed Arms: Baolingbao Biology Co., Ltd. and COFCO Biotechnology Co., Ltd. run large carbohydrate processing bases. Baolingbao lists a feed subsidiary, Yucheng Baolikang Biological Feed, among group companies [12].
• Animal Nutrition and Fiber Platforms: DSM-Firmenich and Roquette Frères bring premix, eubiotic and soluble-fiber know-how that can carry XOS into formulas. DSM-Firmenich opened the first feed additive plant in India at Jadcherla in September 2025 [15].

Competitive Benchmarking

Company	Documented XOS Supply	Animal Nutrition Integration	Functional Carbohydrate Platform	Geographic Reach
Shandong Longlive Bio-Technology Co., Ltd.	High	Medium	High	China and export
Baolingbao Biology Co., Ltd.	Medium	Medium	High	China, Hong Kong, Singapore
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.	High	Medium	Medium	China-based supply
COFCO Biotechnology Co., Ltd.	Low	Medium	High	China
DSM-Firmenich	Low	High	Medium	Nearly 60 countries
Roquette Frères	Low	Medium	High	International

Scoring basis: Documented XOS Supply scores public product evidence for xylooligosaccharide grades. Animal Nutrition Integration scores documented feed, premix or pet-nutrition activity. Functional Carbohydrate Platform scores the breadth of documented functional-sugar, fiber or starch processing. A High score marks broad, clearly documented capability, Medium marks credible but narrower documented capability, and Low marks limited public documentation for the criterion. Scores reflect a review of public company documentation in September 2026.

Key Developments

• In February 2026, Roquette secured NutraStrong Prebiotic Verified certification from SGS Nutrasource for the NUTRIOSE FM 06, FB 06 and FM 15S soluble fibers [14].
• In February 2026, DSM-Firmenich agreed to divest Animal Nutrition & Health to CVC Capital Partners at an enterprise value of EUR 2.2 billion, with closing expected by the end of 2026 [13].
• In May 2026, DSM-Firmenich opened NextGen Itatiba in São Paulo state, Brazil, a pet-dedicated premix site producing vitamin and mineral premixes for cats and dogs [16].

Key Players

Direct XOS Manufacturers

• Shandong Longlive Bio-Technology Co., Ltd.
• Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Functional Sugar Groups with Feed Arms

• Baolingbao Biology Co., Ltd.
• COFCO Biotechnology Co., Ltd.

Animal Nutrition and Fiber Platforms

• DSM-Firmenich
• Roquette Frères

Report Scope and Methodology

Coverage field	Report scope
Market breakdown	2 categories: Form (Dry, Liquid), Product Type (Livestock, Pet), and Region
Quantitative units	USD Million
Market definition	Revenue from xylooligosaccharide ingredient sold for livestock and pet applications in dry or liquid form. The definition excludes downstream finished feed and pet-food revenue, other prebiotics, substitute oligosaccharides, services and adjacent ingredients.
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	More than 25 countries and country groups, including Japan, Canada, the USA, the UK, Germany, France, Italy, and Russia
Key companies profiled	Shandong Longlive Bio-Technology Co., Ltd., Baolingbao Biology Co., Ltd., Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., COFCO Biotechnology Co., Ltd., DSM-Firmenich and Roquette Frères, among many other players covered in the study
Forecast period	2026 to 2036
Approach	A hybrid bottom-up and top-down sizing framework built by FMI reconciles XOS ingredient volumes, grade pricing and supplier revenue signals with livestock inventories, compound feed output and pet food production in each country.

Research Methodology

Method	Approach
Primary research	The primary-research framework engages XOS and functional-sugar producers, premix and compound-feed manufacturers, pet food formulators, distributors and animal nutritionists to test purchase drivers, inclusion rates, approval requirements, pricing and repeat-order conditions.
Desk research	The analysis reviews livestock statistics, feed-additive regulations, peer-reviewed animal trials, company announcements and product information. The study retains sources that define demand, product form, country conditions or supplier activity inside the market boundary.
Market sizing and forecasting	The sizing framework combines the baseline value with segment structure, price and volume indicators by grade, company participation and country-level livestock and pet food demand. Forecasts consider feed regulation, trial evidence, supply capacity and feedstock cost.
Data validation	Estimates are checked against public data, company activity and interview findings. Finished feed, pet food, other prebiotics, overlapping revenues and unsupported claims are excluded before final reconciliation.

Xylooligosaccharide Market by Segments

Xylooligosaccharide Market Segmented by Form

• Dry
• Liquid

Xylooligosaccharide Market Segmented by Product Type

• Livestock
• Pet

Xylooligosaccharide Market Segmented by Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa

Research Sources and Bibliography

• [1] Hu, X. et al. (2026, June 22). The prebiotic potential of xylooligosaccharides: status, challenges, and future prospects. Food, Nutrition and Health.
• [2] Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (2025, July 21). Xylo-oligosaccharides (XOS): Core Properties, Health Benefits, Processing & Future Outlook.
• [3] Ma, W. et al. (2025, September 17). Effects of xylooligosaccharide supplementation on performance, intestinal morphology, antioxidant capacity and cecal microflora in weaning pigs. Frontiers in Veterinary Science.
• [4] Cao, Q. et al. (2025, July 31). Xylooligosaccharide Supplementation Mitigates Growth Performance Impairment and Intestinal Injuries in Enterohemorrhagic Escherichia coli-Challenged Broilers. The Journal of Poultry Science.
• [5] Ministry of Agriculture, Forestry and Fisheries of Japan (2026, August 18). Feed additives.
• [6] Istat (2026, September 4). Produzioni agricole e zootecniche - Anno 2025.
• [7] Dairy Reporter (2026, February 25). Expanding the toolbox: Japan approves methane-cutting feed additive under J-Credit scheme.
• [8] Statistics Canada (2026, August 24). Livestock estimates, July 1, 2026.
• [9] USDA National Agricultural Statistics Service (2026, September 24). United States hog inventory down 2%.
• [10] Department for Environment, Food & Rural Affairs (2026, October 2). Livestock populations in the United Kingdom at 1 June 2025.
• [11] Statistisches Bundesamt (Destatis) (2026, June 26). Zahl der schweinehaltenden Betriebe sinkt weiter: -3,6 % im Mai 2026 gegenüber dem Vorjahr.
• [12] Baolingbao Biology Co., Ltd. (2026, September). Company news and group companies.
• [13] DSM-Firmenich (2026, February 9). dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners.
• [14] Roquette (2026, February 3). NUTRIOSE® Soluble Fibers: NutraStrong™ Prebiotic Verified.
• [15] dsm-firmenich (2025, August 30). dsm-firmenich opens new Animal Nutrition & Health plant in Jadcherla, India
• [16] DSM-Firmenich (2026, May 11). dsm-firmenich expands pet-dedicated premix network with opening of NextGen Itatiba, Sao Paulo, Brazil.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• What will the Xylooligosaccharide Market size be in 2026, and what value will the market reach by 2036?
• Which feed-efficiency and gut-health needs will continue to support demand for xylooligosaccharide?
• Why will dry grades hold the leading position within the Form category in 2026?
• Why will livestock hold the leading position within the Product Type category?
• How will growth rates differ across Japan, Canada, the USA, the UK, Germany, France, Italy, and Russia till 2036?
• How will adjacent feed prebiotic, eubiotic and pet gut-health categories shape revenue opportunities for XOS producers?
• How will feed-additive approval rules and species-specific trials slow conversion from sample to contract?
• How will pet nutrition add a higher-value outlet for low-dose XOS grades?
• What will feed mills and premix buyers need to check before qualifying a new XOS supplier?